Asieris Pharmaceuticals Participated at 2017 BIO International Convention

Shanghai, China, July 17 — Asieris Pharmaceuticals, a clinical stage bio-pharmaceutical company, announced today that it has participated at the 2017 Biotechnology Innovation Organization (BIO) International Convention held on June 19 – 22, 2017 at the San Diego Convention Center.

The BIO International Convention attracted 16,000+ attendees from 5,000+ companies including the leading biotech and pharma companies, top 20 CROs and CMOs, more than 300 academic institutions including the major research labs and government agencies, as well as leading consultants and service companies.

Participation at this forum including hosting a booth  is another step Asieris has taken under its global strategy. During this event, Mr. David Wilson, Senior VP of Business Development, and Ms. Dandan Xie, Senior Manager of Business Development, had extensive interactions with the visitors to the booth and in-depth discussions pertaining to future collaboration opportunities.

Through such international platform, Asieris has obtained much valuable information for our interested markets and products, which has strengthen our foundation for future collaborations. The meeting objectives have been achieved.